Gene: HYKK
Official Full Name: hydroxylysine kinaseprovided by HGNC
Gene Summary: Enables hydroxylysine kinase activity. Predicted to be involved in lysine catabolic process. Predicted to be located in mitochondrial matrix. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28848 | HYKK Knockout cell line (HeLa) | Human | HYKK | 1:3~1:6 | Negative | Online Inquiry |
KO28849 | HYKK Knockout cell line (HCT 116) | Human | HYKK | 1:2~1:4 | Negative | Online Inquiry |
KO28850 | HYKK Knockout cell line (HEK293) | Human | HYKK | 1:3~1:6 | Negative | Online Inquiry |
KO28851 | HYKK Knockout cell line (A549) | Human | HYKK | 1:3~1:4 | Negative | Online Inquiry |
HYKK Gene Knockout Cell Lines are meticulously engineered cellular models in which specific genes have been inactivated or deleted through precise genome-editing techniques. This innovative product enables researchers to investigate gene function, elucidate biological processes, and identify disease mechanisms by examining the phenotypic consequences of gene loss. The HYKK product line utilizes advanced CRISPR-Cas9 technology, allowing for high efficiency and specificity in gene targeting, thus ensuring that unintended off-target effects are minimized.
The primary function of HYKK Gene Knockout Cell Lines revolves around their ability to simulate physiological and pathological states in vitro. By providing a platform for gene disruption, these cell lines facilitate the study of gene function, signal transduction pathways, and cellular responses to various stimuli. Researchers can utilize these models to investigate cancer biology, metabolic disorders, and genetic diseases, among other areas of study.
From a scientific standpoint, HYKK Gene Knockout Cell Lines hold immense value in both research and clinical settings. They not only accelerate the discovery process for drug targets and therapeutic interventions but also serve as vital tools for preclinical testing and validation of novel treatments. Moreover, their robustness and reproducibility make them ideal for downstream applications such as high-throughput screening and in vivo model creation.
Compared to alternatives, HYKK Gene Knockout Cell Lines are distinguished by their validated performance and comprehensive support structure. Each cell line undergoes stringent quality control measures to ensure consistent functionality across different research settings. This reliability enables researchers to focus on their investigations rather than troubleshooting issues commonly associated with less rigorously developed models.
The value of HYKK Gene Knockout Cell Lines to researchers, clinicians, and biopharmaceutical companies is pronounced; they empower users to map complex genetic interactions and accelerate innovation in precision medicine. With a steadfast commitment to scientific excellence, our company leverages extensive expertise in genetic engineering and cell biology to deliver high-quality biological products, positioning ourselves as leaders in the ongoing pursuit of understanding genetic intricacies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.